TNF and Crohn disease: According to Boronat-Toscano et al., anti-tumor necrosis factor therapy suppressed immune cell infiltration in visceral adipose tissue in areas of inflamed gut and restored adipose tissue morphology in a cohort of 14 Crohn’s disease patients receiving anti-tumor necrosis factor biologic agents (36).